ID   ENPP6_MOUSE             Reviewed;         440 AA.
AC   Q8BGN3; Q4VAH5;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 129.
DE   RecName: Full=Glycerophosphocholine cholinephosphodiesterase ENPP6 {ECO:0000305};
DE            Short=GPC-Cpde;
DE            EC=3.1.4.- {ECO:0000269|PubMed:15788404};
DE            EC=3.1.4.38 {ECO:0000269|PubMed:15788404, ECO:0000269|PubMed:26888014};
DE   AltName: Full=Choline-specific glycerophosphodiester phosphodiesterase {ECO:0000303|PubMed:15788404};
DE   AltName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 6;
DE            Short=E-NPP 6;
DE            Short=NPP-6;
DE   Flags: Precursor;
GN   Name=Enpp6 {ECO:0000312|MGI:MGI:2445171};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   TISSUE SPECIFICITY, FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=15788404; DOI=10.1074/jbc.m413438200;
RA   Sakagami H., Aoki J., Natori Y., Nishikawa K., Kakehi Y., Natori Y.,
RA   Arai H.;
RT   "Biochemical and molecular characterization of a novel choline-specific
RT   glycerophosphodiester phosphodiesterase belonging to the nucleotide
RT   pyrophosphatase/phosphodiesterase family.";
RL   J. Biol. Chem. 280:23084-23093(2005).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5] {ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-421 IN COMPLEX WITH
RP   PHOSPHOCHOLINE AND ZINC, GLYCOSYLATION AT ASN-100; ASN-118; ASN-341 AND
RP   ASN-404, SUBUNIT, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DISRUPTION
RP   PHENOTYPE, CATALYTIC ACTIVITY, FUNCTION, COFACTOR, DISULFIDE BOND, AND
RP   MUTAGENESIS OF SER-71; TYR-72; TYR-75; CYS-154; TYR-188; GLU-190; CYS-393
RP   AND CYS-412.
RX   PubMed=26888014; DOI=10.1038/srep20995;
RA   Morita J., Kano K., Kato K., Takita H., Sakagami H., Yamamoto Y.,
RA   Mihara E., Ueda H., Sato T., Tokuyama H., Arai H., Asou H., Takagi J.,
RA   Ishitani R., Nishimasu H., Nureki O., Aoki J.;
RT   "Structure and biological function of ENPP6, a choline-specific
RT   glycerophosphodiester-phosphodiesterase.";
RL   Sci. Rep. 6:20995-20995(2016).
CC   -!- FUNCTION: Choline-specific glycerophosphodiesterase that hydrolyzes
CC       glycerophosphocholine (GPC) and lysophosphatidylcholine (LPC) and
CC       contributes to supplying choline to the cells (PubMed:15788404,
CC       PubMed:26888014). Has a preference for LPC with short (12:0 and 14:0)
CC       or polyunsaturated (18:2 and 20:4) fatty acids (PubMed:15788404). In
CC       vitro, hydrolyzes only choline-containing lysophospholipids, such as
CC       sphingosylphosphorylcholine (SPC), platelet-activating factor (PAF) and
CC       lysoPAF, but not other lysophospholipids (PubMed:15788404).
CC       {ECO:0000269|PubMed:15788404, ECO:0000269|PubMed:26888014}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sn-glycerol 3-phosphocholine = glycerol + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:19545, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16870, ChEBI:CHEBI:17754,
CC         ChEBI:CHEBI:295975; EC=3.1.4.38;
CC         Evidence={ECO:0000269|PubMed:15788404, ECO:0000269|PubMed:26888014};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19546;
CC         Evidence={ECO:0000269|PubMed:26888014};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:44720,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58168,
CC         ChEBI:CHEBI:64683, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44721;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-sn-glycero-3-phosphocholine + H2O = 1-O-alkyl-sn-
CC         glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:36083,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15850,
CC         ChEBI:CHEBI:30909, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36084;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-dodecanoyl-sn-glycero-3-phosphocholine + H2O = 1-dodecanoyl-
CC         sn-glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:41127,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74966,
CC         ChEBI:CHEBI:75529, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41128;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:41119, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:75542, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41120;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:41003, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:34071, ChEBI:CHEBI:74344,
CC         ChEBI:CHEBI:295975; Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41004;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-tetradecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         tetradecanoyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:40999, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:64489, ChEBI:CHEBI:75536, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41000;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sphing-4-enine-phosphocholine = H(+) + phosphocholine +
CC         sphing-4-enine; Xref=Rhea:RHEA:41095, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57756, ChEBI:CHEBI:58906,
CC         ChEBI:CHEBI:295975; Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41096;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O = 1-
CC         (9Z-octadecenoyl)-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:41091, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28610, ChEBI:CHEBI:75757, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41092;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphocholine + H2O =
CC         1-(9Z,12Z-octadecadienoyl)-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:41115, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28733, ChEBI:CHEBI:75561, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000269|PubMed:15788404};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41116;
CC         Evidence={ECO:0000305|PubMed:15788404};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycero-2-phosphocholine + H2O = glycerol + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:61684, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17754, ChEBI:CHEBI:144950,
CC         ChEBI:CHEBI:295975; Evidence={ECO:0000269|PubMed:26888014};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61685;
CC         Evidence={ECO:0000269|PubMed:26888014};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000305|PubMed:26888014};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|PubMed:26888014};
CC   -!- ACTIVITY REGULATION: Inhibited by EDTA and EGTA in vitro.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:26888014). Homotetramer
CC       (PubMed:26888014). {ECO:0000250, ECO:0000269|PubMed:26888014}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor, GPI-
CC       anchor {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in kidney with a lesser
CC       expression in brain and heart (PubMed:15788404, PubMed:26888014). In
CC       the brain and spinal cord, mainly expressed in the white matter. In
CC       oligodendrocytes, is predominantly detected in the myelin sheath. In
CC       the kidney, is predominantly expressed in the luminal side of the renal
CC       tubule in the cortex and in the proximal renal tubules. It is expressed
CC       in liver sinusoidal endothelial cells (PubMed:26888014).
CC       {ECO:0000269|PubMed:15788404, ECO:0000269|PubMed:26888014}.
CC   -!- DEVELOPMENTAL STAGE: At postnatal day 2 (P2) and P4, is detected in
CC       immature oligodendrocytes, where it was predominantly found both in the
CC       processes and cell bodies. In contrast, at P12 and P14, it is found
CC       mainly in myelin sheaths. {ECO:0000269|PubMed:26888014}.
CC   -!- DISRUPTION PHENOTYPE: Enpp6 knockout mice give birth according to the
CC       Mendelian rule and are apparently normal. Mice exhibit mild symptoms of
CC       fatty liver and are more susceptible to a choline-deficient diet and
CC       exhibit severe fatty liver phenotypes at the early stage.
CC       {ECO:0000269|PubMed:26888014}.
CC   -!- SIMILARITY: Belongs to the nucleotide pyrophosphatase/phosphodiesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK046797; BAC32873.1; -; mRNA.
DR   EMBL; AK046881; BAC32906.1; -; mRNA.
DR   EMBL; BC096376; AAH96376.1; -; mRNA.
DR   CCDS; CCDS40335.1; -.
DR   RefSeq; NP_796278.1; NM_177304.4.
DR   PDB; 5EGE; X-ray; 2.00 A; A/B/C/D=1-421.
DR   PDB; 5EGH; X-ray; 1.80 A; A/B=1-421.
DR   PDBsum; 5EGE; -.
DR   PDBsum; 5EGH; -.
DR   SMR; Q8BGN3; -.
DR   STRING; 10090.ENSMUSP00000044608; -.
DR   SwissLipids; SLP:000000637; -.
DR   GlyConnect; 2277; 5 N-Linked glycans (4 sites).
DR   GlyGen; Q8BGN3; 5 sites.
DR   iPTMnet; Q8BGN3; -.
DR   PhosphoSitePlus; Q8BGN3; -.
DR   jPOST; Q8BGN3; -.
DR   MaxQB; Q8BGN3; -.
DR   PaxDb; Q8BGN3; -.
DR   PeptideAtlas; Q8BGN3; -.
DR   PRIDE; Q8BGN3; -.
DR   ProteomicsDB; 275912; -.
DR   Antibodypedia; 28837; 199 antibodies.
DR   Ensembl; ENSMUST00000039840; ENSMUSP00000044608; ENSMUSG00000038173.
DR   GeneID; 320981; -.
DR   KEGG; mmu:320981; -.
DR   UCSC; uc009lqr.1; mouse.
DR   CTD; 133121; -.
DR   MGI; MGI:2445171; Enpp6.
DR   eggNOG; KOG2645; Eukaryota.
DR   GeneTree; ENSGT00940000158457; -.
DR   HOGENOM; CLU_017594_2_0_1; -.
DR   InParanoid; Q8BGN3; -.
DR   OMA; LLPLWWN; -.
DR   OrthoDB; 999163at2759; -.
DR   PhylomeDB; Q8BGN3; -.
DR   TreeFam; TF330032; -.
DR   BRENDA; 3.1.4.3; 3474.
DR   Reactome; R-MMU-6814848; Glycerophospholipid catabolism.
DR   BioGRID-ORCS; 320981; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Enpp6; mouse.
DR   PRO; PR:Q8BGN3; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q8BGN3; protein.
DR   Bgee; ENSMUSG00000038173; Expressed in proximal tubule and 160 other tissues.
DR   ExpressionAtlas; Q8BGN3; baseline and differential.
DR   Genevisible; Q8BGN3; MM.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0047390; F:glycerophosphocholine cholinephosphodiesterase activity; IMP:UniProtKB.
DR   GO; GO:0008889; F:glycerophosphodiester phosphodiesterase activity; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; ISS:UniProtKB.
DR   GO; GO:0019695; P:choline metabolic process; IDA:MGI.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR029889; ENPP6.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   PANTHER; PTHR10151:SF66; PTHR10151:SF66; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Lipoprotein; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Signal; Zinc.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000250"
FT   CHAIN           23..419
FT                   /note="Glycerophosphocholine cholinephosphodiesterase
FT                   ENPP6"
FT                   /id="PRO_0000239363"
FT   PROPEP          420..440
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000420891"
FT   ACT_SITE        71
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255"
FT   METAL           32
FT                   /note="Zinc 1; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           71
FT                   /note="Zinc 1; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           193
FT                   /note="Zinc 2; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           197
FT                   /note="Zinc 2; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           240
FT                   /note="Zinc 1; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           241
FT                   /note="Zinc 1; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   METAL           354
FT                   /note="Zinc 2; via tele nitrogen; catalytic"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   BINDING         32
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   BINDING         71
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   BINDING         92
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   BINDING         193
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   BINDING         241
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   BINDING         354
FT                   /note="Substrate"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGH"
FT   MOD_RES         71
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B0BND0"
FT   LIPID           419
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE"
FT   CARBOHYD        118
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   CARBOHYD        341
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   CARBOHYD        404
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   DISULFID        142..154
FT                   /evidence="ECO:0000269|PubMed:26888014,
FT                   ECO:0007744|PDB:5EGE, ECO:0007744|PDB:5EGH"
FT   DISULFID        412
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         71
FT                   /note="S->A: Almost loss of glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         71
FT                   /note="S->T: Almost loss of glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         72
FT                   /note="Y->A: Highly decreases glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         75
FT                   /note="Y->A: Highly decreases glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         154
FT                   /note="C->A: Highly decreases glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         188
FT                   /note="Y->A: Highly decreases glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         190
FT                   /note="E->A: Highly decreases glycerophosphocholine
FT                   cholinephosphodiesterase activity. Loss of choline
FT                   metabolism."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         393
FT                   /note="C->A: Does not affect glycerophosphocholine
FT                   cholinephosphodiesterase activity; when associated with S-
FT                   412. Does not affect choline metabolism; when associated
FT                   with S-412."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   MUTAGEN         412
FT                   /note="C->S: Does not affect Glycerophosphocholine
FT                   cholinephosphodiesterase activity; when associated withA-
FT                   393. Does not affect choline metabolism; when associated
FT                   with A-393."
FT                   /evidence="ECO:0000269|PubMed:26888014"
FT   CONFLICT        384
FT                   /note="R -> K (in Ref. 2; AAH96376)"
FT                   /evidence="ECO:0000305"
FT   STRAND          25..31
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           36..39
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           41..44
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           48..56
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          57..61
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           71..80
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           84..87
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          92..96
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            97..100
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          101..104
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            105..107
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           109..112
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           114..116
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            117..119
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           123..129
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          134..138
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            140..143
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          152..155
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           163..178
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          183..189
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           191..199
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           204..226
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            230..232
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          233..238
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            248..251
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          252..254
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           255..257
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           261..263
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          264..268
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          271..278
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           283..290
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          296..300
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           301..303
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           306..308
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          318..323
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          328..331
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           333..335
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          342..345
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           361..363
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          367..371
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   STRAND          376..380
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           385..387
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           388..396
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   TURN            408..410
FT                   /evidence="ECO:0007744|PDB:5EGH"
FT   HELIX           411..413
FT                   /evidence="ECO:0007744|PDB:5EGH"
SQ   SEQUENCE   440 AA;  50618 MW;  837B050E93EB7492 CRC64;
     MAAKLWTFLL GFGLSWVWPA SAHRKLLVLL LDGFRSDYIS EDALASLPGF REIVNRGVKV
     DYLTPDFPSL SYPNYYTLMT GRHCEVHQMI GNYMWDPRTN KSFDIGVNRD SLMPLWWNGS
     EPLWITLMKA RRKVYMYYWP GCEVEILGVR PTYCLEYKTV PTDINFANAV SDALDSLKSG
     RADLAAIYHE RIDVEGHHYG PSSPQRKDAL RAVDTVLKYM IQWIQDRGLQ QDLNVILFSD
     HGMTDIFWMD KVIELSNYIS LDDLQQVKDR GPVVSLWPVP GKHSEIYHKL RTVEHMTVYE
     KESIPNRFYY KKGKFVSPLT LVADEGWFIA ESREMLPFWM NSTGKREGWQ RGWHGYDNEL
     MDMRGIFLAI GPDFKSNFRA APIRSVDVYN IMCHVAGITP LPNNGSWSRV VCMLKGQTSS
     APPTPLNSCA LVLILLLYFV
//
